Over 90% of human pathogenic viruses use heparan sulfate features, which NV-387 copies and presents to fool the virus. NV-387 ...

MGM College organized an awareness programme on blood donation and HIV/AIDS at the college auditorium on Saturday, with resource persons from Christian Institute of Health Sciences and Research (CIHSR ...

IN SHORT: Viral posts circulating on Facebook in Kenya and Tanzania claim to show HIV magnified under a microscope, suggesting the virus's anatomy makes it drug-resistant. But the image actually shows ...

NHS staff started testing people who turned up in scores of hospital casualty departments and had to tell thousands that they ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), announced that Nanoviricides CEO Dr Anil ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

SHELTON, CT / ACCESS Newswire / October 27, 2025 / NanoViricides, Inc. (NYSE American: NNVC ) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the ...

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong activity against the Measles virus in cell culture ...

Around 1,000 people at risk of HIV will be offered a new long-acting injection on the NHS if they cannot have pills to protect them from the virus. The cabotegravir injection will be available on the ...

New facility will expand accessibility for HIV/AIDS specialty services, free STI/STD prevention and treatment services, primary medical care and access to non-profit pharmacy services Ribbon-cutting ...